home / stock / gnmk / gnmk news


GNMK News and Press, GenMark Diagnostics Inc. From 01/09/21

Stock Information

Company Name: GenMark Diagnostics Inc.
Stock Symbol: GNMK
Market: NASDAQ
Website: genmarkdx.com

Menu

GNMK GNMK Quote GNMK Short GNMK News GNMK Articles GNMK Message Board
Get GNMK Alerts

News, Short Squeeze, Breakout and More Instantly...

GNMK - These Were the 5 Best Diagnostics Stocks of 2020

It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...

GNMK - Medical Stocks 2021 Outlook: 2 Strong Tailwinds Should Drive Favorable Performance

In my 2020 outlook, which was pre-coronavirus, I argued the case for buying small and microcap medical stocks that were priced for "non-success". This approach worked in 2020. My 2020 themes were gene therapy, targeted oncologics, and less invasive surgery. For 2021, I add SARS CoV-2 ...

GNMK - GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in th...

GNMK - GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. GenMark Diagnostics Inc (NASDAQ: GNMK) Q3 2020 Earnings Call Oct 28, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript

GNMK - GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q3 2020 Results - Earnings Call Transcript

GenMark Diagnostics, Inc. (GNMK) Q3 2020 Earnings Conference Call October 28, 2020, 04:30 PM ET Company Participants Leigh Salvo - Investor Relations, Gilmartin Group LLC Scott Mendel - President and Chief Executive Officer Johnny Ek - Chief Financial Officer Conference Call Participants Ryan...

GNMK - GenMark Diagnostics Reports Third Quarter 2020 Results

CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2020. Third Quarter 2020 Highligh...

GNMK - APTX, GNMK, HXL and RAIL among after-hours movers

Gainers: [[APTX]] +89.3%. [[EMKR]] +14.8%. [[GNMK]] +8.9%. [[CCK]] +6.5%. [[NOK]] +3.8%.Losers: [[RAIL]] -9.6%. [[HXL]] -8.8%. [[BLU]] -6.9%. [[STLD]] -3.4%. [[TEO]] -3.3%. For further details see: APTX, GNMK, HXL and RAIL among after-hours movers

GNMK - GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020

CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, October 28, 2020. Management will hold a conference call to review the company's fin...

GNMK - Better Guidance Fails To Boost GenMark, As The COVID-19 Story No Longer Surprises

GenMark guided to a meaningfully better quarter than the sell-side had expected, with revenue about 12% higher than the average sell-side estimate and strong ePlex system placements. The market may be moving on, assuming that antigen-based testing will become the dominant approach for...

GNMK - ACB, TLRY among premarket gainers

Medigus (MDGS) +32% on buy out of Amazon Marketplace brands.MicroVision (MVIS) +25%.Just Energy Group (JE) +23%. after PIMCO disclosed 28.9% stake in the company.Xilinx (XLNX) +16% as AMD in advance talks to buy the company.Extreme Networks (EXTR) +17% ...

Previous 10 Next 10